Target type: biologicalprocess
The elongation of a fatty acid chain by the sequential addition of two-carbon units. [ISBN:0716720094]
Fatty acid elongation is a crucial metabolic process that extends the carbon chain length of fatty acids. It occurs in the endoplasmic reticulum (ER) of eukaryotic cells and is catalyzed by a series of enzymes known as fatty acid elongases. The process involves the sequential addition of two-carbon units (acetyl-CoA) to the carboxyl end of a pre-existing fatty acyl chain.
The first step involves the activation of the fatty acid substrate by attaching it to coenzyme A (CoA) to form acyl-CoA. Next, the acyl-CoA is transferred to the elongase complex, where it undergoes a series of reactions.
The elongase complex consists of four key enzymes:
* **Acyl-CoA dehydrogenase:** This enzyme oxidizes the fatty acyl-CoA, creating a double bond.
* **Enoyl-CoA hydratase:** This enzyme adds water across the double bond, forming a hydroxyl group.
* **3-hydroxyacyl-CoA dehydrogenase:** This enzyme oxidizes the hydroxyl group to a ketone.
* **Thiolase:** This enzyme cleaves the elongated fatty acyl-CoA from the elongase complex.
The elongated fatty acyl-CoA is then available for further metabolism or incorporation into lipids.
Fatty acid elongation is essential for the synthesis of various important lipids, including:
* **Sphingolipids:** These lipids are critical components of cell membranes and play roles in cell signaling and recognition.
* **Cerebrosides:** These lipids are abundant in the brain and other nervous tissues and contribute to myelin sheath formation.
* **Glycosphingolipids:** These lipids are involved in cell adhesion and recognition.
In addition to its role in lipid synthesis, fatty acid elongation also contributes to:
* **Regulation of membrane fluidity:** The length of fatty acid chains influences membrane fluidity. Elongation increases the length of fatty acid chains, reducing membrane fluidity.
* **Adaptation to cold temperatures:** In cold-blooded animals, fatty acid elongation helps to maintain membrane fluidity at low temperatures.
Fatty acid elongation is a tightly regulated process, with various factors influencing its activity, including:
* **Substrate availability:** The availability of fatty acids and acetyl-CoA is crucial for elongation.
* **Hormonal regulation:** Hormones like insulin and glucagon can modulate elongase activity.
* **Cellular energy status:** The cell's energy status can also influence elongase activity.
Disruptions in fatty acid elongation can lead to various diseases, including:
* **Neurological disorders:** Defects in fatty acid elongation can affect brain development and function.
* **Metabolic disorders:** Abnormal elongation can contribute to metabolic disorders like obesity and diabetes.
Overall, fatty acid elongation is a vital metabolic process with profound implications for cell function and human health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | An enoyl-[acyl-carrier-protein] reductase [NADH] FabI that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0AEK4] | Escherichia coli K-12 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | An enoyl-[acyl-carrier-protein] reductase [NADH] FabI that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0AEK4] | Escherichia coli K-12 |
Compound | Definition | Classes | Roles |
---|---|---|---|
triclosan | aromatic ether; dichlorobenzene; monochlorobenzenes; phenols | antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic | |
evernic acid | evernic acid: RN given refers to parent cpd | carbonyl compound | |
psoromic acid | psoromic acid: structure in first source | carbonyl compound | |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
gallocatechol | (-)-epigallocatechin : A flavan-3,3',4',5,5',7-hexol having (2R,3R)-configuration. | catechin; flavan-3,3',4',5,5',7-hexol | antioxidant; food component; plant metabolite |
xanthorrhizol | xanthorrhizol: structure in first source | sesquiterpenoid | |
epicatechin gallate | (-)-epicatechin-3-O-gallate : A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin. A natural product found in Parapiptadenia rigida. epicatechin gallate: a steroid 5alpha-reductase inhibitor; RN given refers to the (cis)-isomer; structure given in first source; isolated from green tea | catechin; gallate ester; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite |
(+)-usnic acid | usnic acid | ||
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
luteolin | 3'-hydroxyflavonoid; tetrahydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist | |
butein | chalcones; polyphenol | antineoplastic agent; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; geroprotector; hypoglycemic agent; plant metabolite; radiosensitizing agent; tyrosine kinase inhibitor | |
vulpinic acid | vulpinic acid: RN given refers to cpd without isomeric designation; structure given in first source; vulpinic acid refers to (E)-isomer | butenolide |